| Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines AD Yang, F Fan, ER Camp, G van Buren, W Liu, R Somcio, MJ Gray, ... Clinical cancer research 12 (14), 4147-4153, 2006 | 578 | 2006 |
| Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells AD Yang, ER Camp, F Fan, L Shen, MJ Gray, W Liu, R Somcio, TW Bauer, ... Cancer research 66 (1), 46-51, 2006 | 349 | 2006 |
| Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor ER Camp, J Summy, TW Bauer, W Liu, GE Gallick, LM Ellis Clinical Cancer Research 11 (1), 397-405, 2005 | 280 | 2005 |
| Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma NF Esnaola, JE Meyer, A Karachristos, JL Maranki, ER Camp, ... Cancer 122 (9), 1349-1369, 2016 | 240 | 2016 |
| Management of bevacizumab-associated bowel perforation: a case series and review of the literature BD Badgwell, ER Camp, B Feig, RA Wolff, C Eng, LM Ellis, JN Cormier Annals of oncology 19 (3), 577-582, 2008 | 205 | 2008 |
| Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met–and insulin-like growth factor-I receptor–mediated migration and … TW Bauer, W Liu, F Fan, ER Camp, A Yang, RJ Somcio, CD Bucana, ... Cancer research 65 (17), 7775-7781, 2005 | 183 | 2005 |
| RON, a tyrosine kinase receptor involved in tumor progression and metastasis ER Camp, W Liu, F Fan, A Yang, R Somcio, LM Ellis Annals of surgical oncology 12, 273-281, 2005 | 133 | 2005 |
| Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target ER Camp, A Yang, MJ Gray, F Fan, SR Hamilton, DB Evans, AT Hooper, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 130 | 2007 |
| Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer VJ Findlay, C Wang, DK Watson, ER Camp Cancer gene therapy 21 (5), 181-187, 2014 | 125 | 2014 |
| Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy ER Camp, C Wang, EC Little, PM Watson, KF Pirollo, A Rait, DJ Cole, ... Cancer gene therapy 20 (4), 222-228, 2013 | 119 | 2013 |
| Inducible nuclear factor-κB activation contributes to chemotherapy resistance in gastric cancer ER Camp, J Li, DJ Minnich, A Brank, LL Moldawer, SLD MacKay, ... Journal of the American College of Surgeons 199 (2), 249-258, 2004 | 103 | 2004 |
| Minimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance ER Camp, PF McAuliffe, JS Gilroy, CG Morris, DS Lind, NP Mendenhall, ... Journal of the American College of Surgeons 201 (6), 855-861, 2005 | 101 | 2005 |
| Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data VA Smith, ER Camp, EJ Lentsch The Laryngoscope 122 (6), 1283-1290, 2012 | 100 | 2012 |
| Inhibition of NF-Kappa B augments sensitivity to 5-Fluorouracil/Folinic acid in colon cancer1 R Voboril, SN Hochwald, J Li, A Brank, J Weberova, F Wessels, ... Journal of Surgical Research 120 (2), 178-188, 2004 | 86 | 2004 |
| miR-145 antagonizes SNAI1-mediated stemness and radiation resistance in colorectal cancer Y Zhu, C Wang, SA Becker, K Hurst, LM Nogueira, VJ Findlay, ER Camp Molecular Therapy 26 (3), 744-754, 2018 | 85 | 2018 |
| Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors SR Schell, ER Camp, JG Caridi, IF Hawkins Journal of gastrointestinal surgery 6 (5), 664-670, 2002 | 83 | 2002 |
| Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients Y Yang, PD Mauldin, M Ebeling, TC Hulsey, B Liu, MB Thomas, ER Camp, ... Cancer 119 (8), 1512-1520, 2013 | 82 | 2013 |
| The development and characterization of a human midgut carcinoid cell line G Van Buren, A Rashid, AD Yang, EK Abdalla, MJ Gray, W Liu, R Somcio, ... Clinical Cancer Research 13 (16), 4704-4712, 2007 | 71 | 2007 |
| MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer QJ Guo, JN Mills, SG Bandurraga, LM Nogueira, NJ Mason, ER Camp, ... Breast Cancer Research 15, 1-13, 2013 | 61 | 2013 |
| SNAI2 Modulates Colorectal Cancer 5-Fluorouracil Sensitivity through miR145 RepressionThe SNAI2: miR145 Axis and Chemotherapeutic Response VJ Findlay, C Wang, LM Nogueira, K Hurst, D Quirk, SP Ethier, ... Molecular cancer therapeutics 13 (11), 2713-2726, 2014 | 59 | 2014 |
